Flipping the paradigm: From surgery-specific to patient-driven perioperative analgesic algorithms

Anesthesiology

Volumn 122, Issue 4, 2015, Pages 731-733

  Brummett, Chad M ^a   Clauw, Daniel J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ESCITALOPRAM; PLACEBO; CITALOPRAM;

ALGORITHM; ANALGESIA; CATASTROPHIZING; EDITORIAL; FOLLOW UP; HUMAN; OUTCOME ASSESSMENT; PAIN; PERIOPERATIVE PERIOD; PERSONALIZED MEDICINE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURGERY; ADVERSE EFFECTS; CATASTROPHIZATION; FEMALE; KNEE ARTHROPLASTY; MALE; PAIN, POSTOPERATIVE; PROCEDURES;

ANALGESIA; ARTHROPLASTY, REPLACEMENT, KNEE; CATASTROPHIZATION; CITALOPRAM; FEMALE; HUMANS; MALE; PAIN, POSTOPERATIVE; PERIOPERATIVE CARE;

EID: 84929132392     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000598     Document Type: Editorial

References (14)

1. Lunn TH, Frokjaer VG, Hansen TB, Kristensen PW, Lind T, Kehlet H: Analgesic effect of perioperative escitalopram in high pain catastrophizing patients after total knee arthroplasty: A randomized, double-blind, placebo-controlled trial. Anesthesiology 2015; 122:884-94
2. Wong K, Phelan R, Kalso E, Galvin I, Goldstein D, Raja S, Gilron I: Antidepressant drugs for prevention of acute and chronic postsurgical pain: Early evidence and recommended future directions. Anesthesiology 2014; 121:591-608
3. Max MB: Towards physiologically based treatment of patients with neuropathic pain. Pain 1990; 42:131-7
4. Walter C, Lötsch J: Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment. Pain 2009; 146:270-5
5. Klepstad P, Fladvad T, Skorpen F, Bjordal K, Caraceni A, Dale O, Davies A, Kloke M, Lundström S, Maltoni M, Radbruch L, Sabatowski R, Sigurdardottir V, Strasser F, Fayers PM, Kaasa S; European Palliative Care Research Collaborative (EPCRC); European Association for Palliative Care Research Network: Influence from genetic variability on opioid use for cancer pain: A European genetic association study of 2294 cancer pain patients. Pain 2011; 152:1139-45
6. Yarnitsky D, Granot M, Nahman-Averbuch H, Khamaisi M, Granovsky Y: Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy. Pain 2012; 153:1193-8
7. Demant DT, Lund K, Vollert J, Maier C, Segerdahl M, Finnerup NB, Jensen TS , Sindrup SH : The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: A randomised, double-blind, placebo-controlled phenotypestratified study. Pain 2014; 155:2263-73
8. Dharmshaktu P, Tayal V, Kalra BS: Efficacy of antidepressants as analgesics: A review. J Clin Pharmacol 2012; 52:6-17
9. Otsuka N, Kiuchi Y, Yokogawa F, Masuda Y, Oguchi K, Hosoyamada A: Antinociceptive efficacy of antidepressants: Assessment of five antidepressants and four monoamine receptors in rats. J Anesth 2001; 15:154-8
10. Arnold LM, Hudson JI, Wang F, Wohlreich MM, Prakash A, Kajdasz DK, Chappell AS: Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder. Clin J Pain 2009; 25:461-8
11. Clauw DJ: Fibromyalgia: A clinical review. JAMA 2014; 311:1547-55
12. Wolfe F: Fibromyalgianess. Arthritis Rheum 2009; 61:715-6
13. Brummett CM, Janda AM, Schueller CM, Tsodikov A, Morris M, Williams DA, Clauw DJ: Survey criteria for fibromyalgia independently predict increased postoperative opioid consumption after lower-extremity joint arthroplasty: A prospective, observational cohort study. Anesthesiology 2013; 119:1434-43
14. Memtsoudis SG , Sun X, Chiu YL , Stundner O, Liu SS , Banerjee S, Mazumdar M, Sharrock NE: Perioperative comparative effectiveness of anesthetic technique in orthopedic patients. Anesthesiology 2013; 118:1046-58